AA
SCMP

AQR Arbitrage’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

AQR Arbitrage’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-521,010
Closed -$9.35M – 469
2017
Q4 		$9.35M Buy
+521,010
New +$6.41M 0.11% 137
2015
Q2 		– Sell
-126,000
Closed -$1.96M – 470
2015
Q1 		$1.96M Buy
+126,000
New +$1.95M 0.03% 239

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

AQR Arbitrage's SCMP Position: Q1 2018 in Review

AQR Arbitrage sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 521,010 shares — an estimated $9.35M sold.

AQR Arbitrage first reported a position in SCMP in Q1 2015 and held it in 2 quarters. The position peaked at $9.35M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • AQR Arbitrage reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • AQR Arbitrage sold 521,010 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $9.35M.
  • AQR Arbitrage first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • AQR Arbitrage's Sucampo Pharmaceuticals, Inc. position peaked at $9.35M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on AQR Arbitrage's 13F filing for Q1 2018, filed 15 May 2018.